Analyzes hundreds of cancer-related genes to identify mutations, fusions, and amplifications from tumor or blood samples.
Tests like FoundationOne CDx are FDA-approved for guiding therapy decisions in various cancers, ensuring regulatory compliance and clinical validity.
Offers non-invasive testing via blood samples (e.g., FoundationOne Liquid CDx) for monitoring treatment response and detecting resistance mutations.
Delivers detailed reports with actionable insights, including therapy matches, clinical trial options, and prognostic information.
Seamlessly integrates reports into electronic health records (EHR) for easy access by healthcare providers.
Collaborates with laboratories and institutions worldwide to offer testing services and support research initiatives.
Helps oncologists select EGFR, ALK, or other targeted inhibitors based on specific genomic alterations in non-small cell lung cancer.
Assesses PD-L1 expression, tumor mutational burden, and microsatellite instability to determine eligibility for checkpoint inhibitors.
Identifies biomarkers that qualify patients for experimental therapies, accelerating enrollment in oncology trials.
Uses blood-based tests to track genomic changes during therapy, detecting resistance early and adjusting treatment plans.
Analyzes HER2, BRCA, and other mutations to predict outcomes and inform adjuvant or neoadjuvant strategies.
Identifies KRAS, NRAS, or BRAF alterations that indicate resistance to anti-EGFR therapies, guiding alternative options.
Provides genomic insights for hard-to-diagnose cancers, aiding in classification and personalized management.
Reveals multiple actionable targets to design synergistic drug combinations for advanced cancers.
Supports pharmaceutical companies by identifying biomarkers for new drug targets and validating therapies in trials.
Detects germline mutations in genes like BRCA1/2 to assess familial cancer risks and guide preventive measures.
Sign in to leave a review
AddictionRecovery AI is an innovative digital health platform leveraging artificial intelligence to support individuals in overcoming various addictions, including substance abuse, alcohol dependency, and behavioral issues. It offers personalized recovery plans tailored through machine learning algorithms that analyze user data, such as progress logs and triggers, to provide adaptive recommendations. The platform features real-time monitoring tools, AI-powered chatbots for 24/7 emotional support, and cognitive behavioral therapy exercises to help manage cravings. Designed with privacy in mind, it complies with healthcare regulations like HIPAA, ensuring secure data handling. Additionally, it integrates community features for peer support and healthcare provider portals for collaborative care, aiming to enhance recovery outcomes through evidence-based, technology-driven interventions that bridge clinical treatment with daily life management.
Akili Interactive is a pioneering digital therapeutics company that develops and distributes FDA-cleared video game-based treatments for cognitive disorders, primarily focusing on conditions like attention deficit hyperactivity disorder (ADHD) in children. Their flagship product, EndeavorRx, is designed as a prescription digital therapeutic that targets specific neural networks through engaging gameplay to improve attention and focus. Founded on rigorous clinical research, Akili's platforms combine cutting-edge neuroscience with interactive technology to deliver personalized interventions. The company aims to provide safe, effective, and accessible alternatives to traditional pharmaceuticals, with applications in healthcare settings, telehealth, and home use. Akili Interactive is committed to advancing digital medicine by leveraging game mechanics to enhance cognitive functions, backed by regulatory approvals and ongoing studies for broader mental health applications.
Amwell is a leading telehealth platform that enables patients to connect with licensed healthcare providers through secure video consultations, offering a comprehensive range of services including urgent care, behavioral health, chronic condition management, and specialty consultations. Designed to provide convenient, accessible, and high-quality medical care from home, Amwell integrates with various health systems and insurance plans, making it a versatile solution for individuals, employers, and healthcare organizations. Key features include appointment scheduling, secure messaging, electronic health record (EHR) integration, and mobile app access for both iOS and Android. The platform emphasizes privacy and security, complying with healthcare regulations like HIPAA, and aims to reduce barriers to care by streamlining the healthcare experience. With a focus on improving patient outcomes, Amwell supports follow-up care, prescription management, and wellness programs, ensuring that users can receive timely and effective medical attention anytime, anywhere.
